Delivery Order SPE2DB24D8002-SPE2DB25FJMTP
Award Date
11/22/24
Potential Completion Date
11/25/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,035.10 firm fixed-price delivery order (SPE2DX15D8003|SPE2DX24F7C7D) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a period of performance through February 12, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $2,778.75 to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTOR medication and has a completion date of May 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows Dakota Drug, Inc. to...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,046.23, is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a firm fixed price pricing type and a performance period ending on March 25, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order valued at $2,528.44 and has a firm fixed price pricing type. It is not a set-aside contract. The contract is for the provision of pharmaceutical products, specifically Aimovig 140 mg/ml autoinjectors, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the DLA Troop Support Medical, a component of the Defense Logistics Agency (DLA), to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,072.06 contract is for the supply of the pharmaceutical product Aimovig 70 mg/mL autoinjector. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Dakota Drug, Inc. has an extensive history of providing pharmaceuticals, medical...
The federal contract award, identified as SPE2DB24D8002 and SPE2DB25FJNJF, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $1,993.04, is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a performance period ending on March 20, 2025. The contract is not set-aside and is part of a larger Indefinite...
This federal contract award, identified as SPE2DB24D8001 and SPE2DB25FKZHX, was granted by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order valued at $1,667.25 with a Firm Fixed Price pricing type and an ultimate completion date of March 10, 2025. The contract is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to support the medical operations of the U.S. Armed Forces....
This firm fixed-price delivery order contract was awarded by the Department of Defense (DoD), specifically the Defense Logistics Agency (DLA) Troop Support Medical, to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $2,717.38, is for the supply of the prescription medication AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has an ultimate completion date of May 14, 2024 and was awarded on May 13, 2024...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $5,198.70. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML and has an ultimate completion date of May 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a $4,712.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. This order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of...